ID

4282

Description

The purpose of this Phase II study is to determine if AZD4877, an experimental drug that is a novel anti-mitotic agent (Eg5 or Kinesin Spindle Protein inhibitor that interferes with tumor cell division leading to tumor growth), can reduce tumor sizes in patients with bladder cancer

Mots-clés

  1. 06/12/2013 06/12/2013 - Martin Dugas
Téléchargé le

6 décembre 2013

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0 Legacy

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility DRKS00004052 NCT00661609 Advanced Bladder Cancer

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion criteria
Description

Inclusion criteria

Alias
NCI Metathesaurus CUI
C1512693
Confirmed urothelial cancer (cancer of the bladder, renal pelvis, ureter, or urethra).
Description

Confirmed urothelial cancer

Type de données

boolean

Alias
NCI Metathesaurus CUI
CL363966
Tumor, Node, Metastasis (TNM) Stage IV urothelial cancer that can not be helped by curative surgery and/or curative radiotherapy
Description

Disease stage

Type de données

boolean

Alias
NCI Metathesaurus CUI
C0474940
Must have had a maximum of 2 prior chemotherapeutic regimens, one for unremovable and/or metastasized disease, and the other in the adjuvant or neo-adjuvant setting.
Description

Chemotherapie

Type de données

boolean

Alias
NCI Metathesaurus CUI
C1518470
Ambulatory and capable of all selfcare more than 50% of waking hours
Description

Selfcare

Type de données

boolean

Alias
NCI Metathesaurus CUI
C0036592
Exclusion criteria
Description

Exclusion criteria

Alias
NCI Metathesaurus CUI
C0680251
Prior treatment with investigational or standard anti-cancer agents, including radiotherapy, within 4 weeks prior to first dose of study medication; 6 weeks if prior systemic mitomycin, nitrosourea, or suramin.
Description

Prior treatment

Type de données

boolean

Alias
NCI Metathesaurus CUI
C1522449
NCI Metathesaurus CUI
C0949266
Inadequate bone marrow reserve
Description

Bone marrow

Type de données

boolean

Alias
NCI Metathesaurus CUI
C0005953
Inadequate liver function in the presence of liver metastases
Description

Liver function

Type de données

boolean

Alias
NCI Metathesaurus CUI
C0232744
Impaired renal function
Description

Renal function

Type de données

boolean

Alias
NCI Metathesaurus CUI
C0341697

Similar models

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Inclusion criteria
C1512693 (NCI Metathesaurus CUI)
Confirmed urothelial cancer
Item
Confirmed urothelial cancer (cancer of the bladder, renal pelvis, ureter, or urethra).
boolean
CL363966 (NCI Metathesaurus CUI)
Disease stage
Item
Tumor, Node, Metastasis (TNM) Stage IV urothelial cancer that can not be helped by curative surgery and/or curative radiotherapy
boolean
C0474940 (NCI Metathesaurus CUI)
Chemotherapie
Item
Must have had a maximum of 2 prior chemotherapeutic regimens, one for unremovable and/or metastasized disease, and the other in the adjuvant or neo-adjuvant setting.
boolean
C1518470 (NCI Metathesaurus CUI)
Selfcare
Item
Ambulatory and capable of all selfcare more than 50% of waking hours
boolean
C0036592 (NCI Metathesaurus CUI)
Item Group
Exclusion criteria
C0680251 (NCI Metathesaurus CUI)
Prior treatment
Item
Prior treatment with investigational or standard anti-cancer agents, including radiotherapy, within 4 weeks prior to first dose of study medication; 6 weeks if prior systemic mitomycin, nitrosourea, or suramin.
boolean
C1522449 (NCI Metathesaurus CUI)
C0949266 (NCI Metathesaurus CUI)
Bone marrow
Item
Inadequate bone marrow reserve
boolean
C0005953 (NCI Metathesaurus CUI)
Liver function
Item
Inadequate liver function in the presence of liver metastases
boolean
C0232744 (NCI Metathesaurus CUI)
Renal function
Item
Impaired renal function
boolean
C0341697 (NCI Metathesaurus CUI)

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial